Molecule Group plc, formerly Vulcan Two Group plc, is a United Kingdom-based company. The Company is focused on building a regulated ePharmacy platform through its buy-and-build. The Company has a diversified platform spanning business-to-business (B2B) prescription fulfillment and (B2C) digital pharmacy services. Its B2B platform is Molecule CloudRx, which is a regulated digital end-to-end prescription platform and B2B2C dispensing pharmacy, powered by a proprietary technology stack. Its B2C platforms are Molecule Clinic, Molecule through its own consumer-facing website. The Molecule Veterinary is a regulated Pharmacy, and Molecule Veterinary. The Molecule Clinic is a regulated B2C online clinic that prescribes and distributes weight loss and other lifestyle medications through a consumer-facing online consulting platform. Molecule Pharmacy is an over the counter (OTC) pharmacy offered and distributed digital pharmacy, dispensing and distributing private veterinary medications.
Back to dashboard
Company Information
About this company
Key people
Susan Elizabeth Clement Davies
Non-Executive Independent Chairman of the Board
Michael Benjamin Kraftman
Chief Executive Officer, Executive Director
Keith Butcher
Chief Financial Officer, Executive Director
Brendan Celestine O'Brien
Chief Operating Officer, Executive Director
Declan Lismore
Chief Pharmacy Officer
Martin James Glanfield
Non-Executive Independent Director
David Wong
Non-Executive Independent Director
Click to see more
Key facts
- Shares in issue27.28m
- EPICMOL
- ISINGB00BTQLZH16
- LocationUnited Kingdom
- SectorFinancial
- IndustryMisc. Financial Services
- Market cap£56.19m
- Employees-
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.